Article
The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
Transplantation - 1 Jul 2017
Roberts Veena, Campbell Duncan J, Lu Bo, Chia Joanne, Cowan Peter J, Dwyer Karen M
Abstract excerpt
BACKGROUND: Renal ischemia-reperfusion injury (IRI) leads to acute kidney injury and renal fibrosis. CD39 is a key purinergic enzyme in the hydrolysis of adenosine triphosphate (ATP) and increased CD39 enzymatic activity protects from acute IRI but its effect on renal fibrosis is not known. METHODS: Using a mouse model of unilateral renal IRI, the effects of increased CD39 activity (using soluble apyrase and mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
